http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea
서미혜,이원영,김성수,강재헌,강지현,김경곤,김보연,김양현,김원준,김은미,김현수,신윤아,신혜정,이규래,이기영,이상엽,이성규,이주호,이창범,정소정,조영혜,최경묵,한정순,유순집,대한비만학회 진료지침위원회 대한비만학회 2019 The Korean journal of obesity Vol.28 No.1
Obesity increases the risks of diabetes, hypertension, and cardiovascular diseases, ultimately contributing to mortality. Korean Society for the Study of Obesity (KSSO) was established to improve the management of obesity through research and education; to that end, the Committee of Clinical Practice Guidelines of KSSO reviews systemic evidence using expert panels to develop clinical guidelines. The clinical practice guidelines for obesity were revised in 2018 using National Health Insurance Service Health checkup data from 2006 to 2015. Following these guidelines, we added a category, class III obesity, which includes individuals with body mass index (BMI) ≥35 kg/m2. Agreeing with the International Federation for the Surgery of Obesity and Metabolic Disorders, Asian Pacific Chapter consensus, we determined that bariatric surgery is indicated for Korean patients with BMI ≥35 kg/m2 and for Korean patients with BMI ≥30 kg/m2 who have comorbidities. The new guidelines focus on guiding clinicians and patients to manage obesity more effectively. Our recommendations and treatment algorithms can serve as a guide for the evaluation, prevention, and management of overweight and obesity.
2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea
김보연,강선미,강지현,강서영,김경곤,김경배,김범택,김승준,김양현,김정환,김재현,김은미,남가은,박지연,손장원,신윤아,신혜정,오태정,이혁,전언주,정소정,홍용희,김종화,대한비만학회 진료지침위원회 대한비만학회 2021 The Korean journal of obesity Vol.30 No.2
Obesity is a prevalent and complex disease. The prevalence of obesity in Korea increased from 29.7% in 2010 to 35.7% in 2018, with the prevalence of abdominal obesity being 23.8% in 2018. Obesity contributes to medical costs and socioeconomic burden due to associated comorbidities. The treatment and management of obesity is changing based on new clinical evidence. The 2020 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea summarizes evidence-based recommendations and treatment guidelines.
김경곤,함지희,김범택,김은미,박정환,이상열,전언주,강은구,남가은,구혜연,임정현,정조은,김종희,김종원,박정하,홍준화,Sang Eok Lee,민세희,김승준,김선영,김양현,이연지,조윤정,이영준,김연희,강지현,이창범,대한비만학회 진료지침위원회 대한비만학회 2023 Journal of obesity & metabolic syndrome Vol.32 No.1
The goal of the 8th edition of the Clinical Practice Guidelines for Obesity is to help primary care physician provide safe, effective care to patients with obesity by offering evidence-based recommendations to improve the quality of treatment. The Committee for Clinical Practice Guidelines comprised individuals with multidisciplinary expertise in obesity management. A steering board of seven experts oversaw the entire project. Recommendations were developed as the answers to key questions formulated in patient/problem, intervention, comparison, outcomes (PICO) format. Guidelines underwent multi-level review and cross-checking and received endorsement from relevant scientific societies. This edition of the guidelines includes criteria for diagnosing obesity, abdominal obesity, and metabolic syndrome; evaluation of obesity and its complications; weight loss goals; and treatment options such as diet, exercise, behavioral therapy, pharmacotherapy, and bariatric and metabolic surgery for Korean people with obesity. Compared to the previous edition of the guidelines, the current edition includes five new topics to keep up with the constantly evolving field of obesity: diagnosis of obesity, obesity in women, obesity in patients with mental illness, weight maintenance after weight loss, and the use of information and communication technology-based interventions for obesity treatment. This edition of the guidelines features has improved organization, more clearly linking key questions in PICO format to recommendations and key references. We are confident that these new Clinical Practice Guidelines for Obesity will be a valuable resource for all healthcare professionals as they describe the most current and evidence-based treatment options for obesity in a well-organized format.